Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer drug
Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...
Pineapple Energy Announces Distribution to Contingent Value Rights Holders
Our new leadership team continues to author a new future for Pineapple Energy, with a focus on elevating our corporate governance, properly aligning our cost structure, creating a new corporate ...
Hosted on MSN1mon
UMB to refile $6.4B lawsuit against Bristol-Myers by end of next week - report
UMB Financial plans to refile a $6.4 billion against Bristol-Myers Squibb by shareholders owning contingent value rights over its acquisition of Celgene. UMB plans to refile a lawsuit by the end ...
Nasdaq6d
Lumos Pharma Faces Uncertainty as CVRs Risk Expiring Worthless Post-Merger
Lumos Pharma, Inc. faces a significant risk concerning the potential valueless expiration of the Contingent Value Rights (CVRs) offered to stockholders post-2024 Merger and Offer completion.
Pineapple Energy announces 35c distribution to CVR holders
Pineapple Energy (PEGY) will distribute to the holders of its non-transferable Contingent Value Rights a payment of $850,269, or $0.35 per CVR.